ENT · Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes)

A 62-year-old male has a clinically N2b neck (multiple ipsilateral nodes, largest 3.5 cm, no extranodal extension on imaging). Following concurrent chemoradiotherapy, residual lymphadenopathy persists at 10 weeks. What is the appropriate next step?

  • A Immediate salvage neck dissection
  • B Repeat PET-CT at 6 months
  • C Fine needle aspiration of the residual node
  • D PET-CT at 12 weeks post-treatment completion
Correct answer: D. PET-CT at 12 weeks post-treatment completion

Explanation

Current evidence-based guidelines recommend PET-CT at 12 weeks post-completion of chemoradiotherapy to assess neck response, as earlier imaging can have false-positive results due to inflammation and post-treatment changes. A negative PET-CT at 12 weeks has high negative predictive value (>95%) for neck disease, obviating the need for planned neck dissection. Salvage neck dissection is reserved for PET-confirmed persistent disease. FNAC alone is not reliable for post-treatment assessment.

Reference: Dhingra Diseases of Ear, Nose and Throat, 7th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes) MCQs

See all Head and Neck Oncology — Staging and Management (Oral, Laryngeal, Salivary, Neck Nodes) MCQs →